Silver Book Fact

Medicare beneficiaries with vision loss incur significantly higher costs than individuals with normal vision. Approximately 90% of the higher annual costs are non-eye related medical costs– $2,193 for those with moderate loss, $3,301 for those with severe loss, and $4,443 for those who are blind. Extrapolating to the entire Medicare population, blindness and vision loss are associated with $2.14 billion in non-eye related costs (in 2003 dollars).

Javitt J, Zhou Z, Wilke R. Association Between Vision Loss and Higher Medical Care Costs in Medicare Beneficiaries: Costs are greater for those with progressive vision loss. Ophthalmology. 2007; 114(2): 238-45. http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17270673&dopt=AbstractPlus

Reference

Title
Association Between Vision Loss and Higher Medical Care Costs in Medicare Beneficiaries: Costs are greater for those with progressive vision loss
Publication
Ophthalmology
Publication Date
2007
Authors
Javitt J, Zhou Z, Wilke R
Volume & Issue
Volume 114, Issue 2
Pages
238-45
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Up to 80% of diabetics who have had the disease for 10 years or more are affected by diabetic retinopathy.  
  • The average cost in 2004 per diabetic retinopathy patient age 40 to 64 using outpatient services was $629. The average cost per patient 65 years and older was $463.  
  • The number of cases of visual impairment and blindness from age-related macular degeneration (AMD0 is projected to increase from 620,000 in 2010 to 1.6 million in 2050–assuming no treatments.  
  • Estimated Specific Prevalence Rates for AMD  
  • The number of cases of early age-related macular degeneration (AMD) is projected to increase from 9.1 million in 2010 to 17.8 million in 2050.